Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.2850
-0.0134 (-4.49%)
At close: Nov 19, 2025, 4:00 PM EST
0.2851
+0.0001 (0.04%)
Pre-market: Nov 20, 2025, 5:32 AM EST
Applied Therapeutics Market Cap
Applied Therapeutics has a market cap or net worth of $41.13 million as of November 20, 2025. Its market cap has decreased by -96.13% in one year.
Market Cap
41.13M
Enterprise Value
31.68M
1-Year Change
-96.13%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since May 14, 2019, Applied Therapeutics's market cap has decreased from $160.29M to $41.13M, a decrease of -74.34%. That is a compound annual growth rate of -18.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 41.13M | -58.72% |
| Dec 31, 2024 | 99.62M | -61.49% |
| Dec 29, 2023 | 258.72M | 608.33% |
| Dec 30, 2022 | 36.52M | -84.43% |
| Dec 31, 2021 | 234.63M | -52.60% |
| Dec 31, 2020 | 494.96M | -2.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 939.79B |
| Johnson & Johnson | 487.91B |
| AbbVie | 411.64B |
| UnitedHealth Group | 279.99B |
| AstraZeneca | 275.69B |
| Novartis AG | 243.58B |
| Merck & Co. | 235.92B |
| Abbott Laboratories | 219.36B |